These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 31130512)

  • 1. OLIG2 Drives Abnormal Neurodevelopmental Phenotypes in Human iPSC-Based Organoid and Chimeric Mouse Models of Down Syndrome.
    Xu R; Brawner AT; Li S; Liu JJ; Kim H; Xue H; Pang ZP; Kim WY; Hart RP; Liu Y; Jiang P
    Cell Stem Cell; 2019 Jun; 24(6):908-926.e8. PubMed ID: 31130512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of improved human cerebral organoids from single copy DYRK1A knockout induced pluripotent stem cells in trisomy 21: hypothetical solutions for neurodevelopmental models and therapeutic alternatives in down syndrome.
    Çağlayan ES
    Cell Biol Int; 2016 Dec; 40(12):1256-1270. PubMed ID: 27743462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olig2 defines a subset of neural stem cells that produce specific olfactory bulb interneuron subtypes in the subventricular zone of adult mice.
    Del Águila Á; Adam M; Ullom K; Shaw N; Qin S; Ehrman J; Nardini D; Salomone J; Gebelein B; Lu QR; Potter SS; Waclaw R; Campbell K; Nakafuku M
    Development; 2022 Mar; 149(5):. PubMed ID: 35132995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olig2 regulates Purkinje cell generation in the early developing mouse cerebellum.
    Ju J; Liu Q; Zhang Y; Liu Y; Jiang M; Zhang L; He X; Peng C; Zheng T; Lu QR; Li H
    Sci Rep; 2016 Jul; 6():30711. PubMed ID: 27469598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OLIG2 over-expression impairs proliferation of human Down syndrome neural progenitors.
    Lu J; Lian G; Zhou H; Esposito G; Steardo L; Delli-Bovi LC; Hecht JL; Lu QR; Sheen V
    Hum Mol Genet; 2012 May; 21(10):2330-40. PubMed ID: 22343408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pluripotent Stem Cell-Derived Cerebral Organoids Reveal Human Oligodendrogenesis with Dorsal and Ventral Origins.
    Kim H; Xu R; Padmashri R; Dunaevsky A; Liu Y; Dreyfus CF; Jiang P
    Stem Cell Reports; 2019 May; 12(5):890-905. PubMed ID: 31091434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DSCAM/PAK1 pathway suppression reverses neurogenesis deficits in iPSC-derived cerebral organoids from patients with Down syndrome.
    Tang XY; Xu L; Wang J; Hong Y; Wang Y; Zhu Q; Wang D; Zhang XY; Liu CY; Fang KH; Han X; Wang S; Wang X; Xu M; Bhattacharyya A; Guo X; Lin M; Liu Y
    J Clin Invest; 2021 Jun; 131(12):. PubMed ID: 33945512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal mitochondria in Down syndrome iPSC-derived GABAergic interneurons and organoids.
    Xu L; Huo HQ; Lu KQ; Tang XY; Hong Y; Han X; Fu ZX; Fang KH; Xu M; Guo X; Liu Y
    Biochim Biophys Acta Mol Basis Dis; 2022 Jun; 1868(6):166388. PubMed ID: 35301086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of neurogenesis and cortical development in transgenic mice misexpressing Olig2, a gene in the Down syndrome critical region.
    Liu W; Zhou H; Liu L; Zhao C; Deng Y; Chen L; Wu L; Mandrycky N; McNabb CT; Peng Y; Fuchs PN; Lu J; Sheen V; Qiu M; Mao M; Lu QR
    Neurobiol Dis; 2015 May; 77():106-16. PubMed ID: 25747816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prox1 regulates Olig2 expression to modulate binary fate decisions in spinal cord neurons.
    Kaltezioti V; Antoniou D; Stergiopoulos A; Rozani I; Rohrer H; Politis PK
    J Neurosci; 2014 Nov; 34(47):15816-31. PubMed ID: 25411508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurogenesis impairment: An early developmental defect in Down syndrome.
    Stagni F; Giacomini A; Emili M; Guidi S; Bartesaghi R
    Free Radic Biol Med; 2018 Jan; 114():15-32. PubMed ID: 28756311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling Down Syndrome with Patient iPSCs Reveals Cellular and Migration Deficits of GABAergic Neurons.
    Huo HQ; Qu ZY; Yuan F; Ma L; Yao L; Xu M; Hu Y; Ji J; Bhattacharyya A; Zhang SC; Liu Y
    Stem Cell Reports; 2018 Apr; 10(4):1251-1266. PubMed ID: 29526735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosage Counts: Correcting Trisomy-21-Related Phenotypes in Human Organoids and Xenografts.
    Manley WF; Anderson SA
    Cell Stem Cell; 2019 Jun; 24(6):835-836. PubMed ID: 31173710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of Urine-Derived Induced Pluripotent Stem Cells and Cerebral Organoids for Modeling Down Syndrome.
    Teles E Silva AL; Yokota BY; Sertié AL; Zampieri BL
    Stem Cell Rev Rep; 2023 May; 19(4):1116-1123. PubMed ID: 36652145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurons Derived from Human Induced Pluripotent Stem Cells Integrate into Rat Brain Circuits and Maintain Both Excitatory and Inhibitory Synaptic Activities.
    Yin X; Xu JC; Cho GS; Kwon C; Dawson TM; Dawson VL
    eNeuro; 2019; 6(4):. PubMed ID: 31413152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-Dependent Decline in Fate Switch from NG2 Cells to Astrocytes After Olig2 Deletion.
    Zuo H; Wood WM; Sherafat A; Hill RA; Lu QR; Nishiyama A
    J Neurosci; 2018 Feb; 38(9):2359-2371. PubMed ID: 29382710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular Mechanism Underlying Abnormal Differentiation of Neural Progenitor Cells in the Developing Down Syndrome Brain].
    Kurabayashi N; Sanada K
    Yakugaku Zasshi; 2017; 137(7):795-800. PubMed ID: 28674289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro modeling for inherited neurological diseases using induced pluripotent stem cells: from 2D to organoid.
    Nam KH; Yi SA; Jang HJ; Han JW; Lee J
    Arch Pharm Res; 2020 Sep; 43(9):877-889. PubMed ID: 32761309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of iPSC-derived Human Brain Organoids to Model Early Neurodevelopmental Disorders.
    Gabriel E; Gopalakrishnan J
    J Vis Exp; 2017 Apr; (122):. PubMed ID: 28448044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3D brain Organoids derived from pluripotent stem cells: promising experimental models for brain development and neurodegenerative disorders.
    Lee CT; Bendriem RM; Wu WW; Shen RF
    J Biomed Sci; 2017 Aug; 24(1):59. PubMed ID: 28822354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.